Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis
about
Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitroSeparating the anti-apoptotic and mitotic roles of survivinActivation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritisSurvivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR.Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancerThe proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.The role of survivin in diagnosis, prognosis and treatment of breast cancer.Expression of survivin protein in pterygium and relationship with oxidative DNA damagePrognostic relevance of survivin in pancreatic endocrine tumorsClinical correlation of nuclear survivin in esophageal squamous cell carcinoma.Survivin study: an update of "what is the next wave"?Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivinTranscriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment.Identification and characterization of PNRC splicing variants.Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.IAP-targeted therapies for cancer.Survivin: a target from brain cancer to neurodegenerative disease.Clinico-pathologic relevance of Survivin splice variant expression in cancerMonitoring survivin expression in cancer: implications for prognosis and therapy.Survivin splice variants and their diagnostic significance.Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs.Liaisons between survivin and Plk1 during cell division and cell death.(-)-Epigallocatechin-3-gallate Modulates the Differential Expression of Survivin Splice Variants and Protects Spermatogenesis During Testicular Torsion.Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell.Expression of survivin and its four splice variants in colorectal cancer and its clinical significances.Nuclear survivin has reduced stability and is not cytoprotective.Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker.
P2860
0f2ccce2cd7b4dc539fded5e972c611a6f94cad513c64f926f8561bed695d9993f0257d5298c26384ddecaa0c5e9605510dc186cc67fb877e51d253d63d02d9b2ecd53df250eb2e4af392ce87e47142a66916bd653829f6dc2bd1678731ab3bd3e92a8c178d6f3022d36dd935976dfb3c343becb1be15398b10b9b836357f773476e2cccbce09b3b541cab17ddff53d8047586be6adf63dd53b0b4cc926c2d3afccb686db95039704fe05664b3eba3f647734109
P248
Q24337784-8E189E20-427B-4E42-9CBE-F867A80BAD15Q28261657-1A7FF8D6-7BA7-401A-BF47-240071D430FFQ34452194-B57BB1E5-7559-4E98-BB93-326AFEADE0BBQ34757482-32AE15ED-B722-4907-97ED-46920796ED43Q35024933-02FFF1BF-6F57-4DE5-B061-F2BBA40DD02BQ35635793-15B88563-C1B6-43E8-AA16-C9BFDEEE6008Q35667653-983E90A5-CD3A-4EB3-8809-EC11691B3152Q35886671-5E1B596A-4EA2-45E6-B3F6-E79C8AFAC88FQ35947272-16FC0671-F929-45BA-A750-B266C06AF3DCQ36420885-BE06314F-0897-48AC-AEA6-C0CEC9839287Q36430244-72E0250C-C6D0-4BCF-AF76-8BE4C35FECD6Q36603591-4676300F-D5EC-4A5E-A8D2-7EFF4FBEB5D5Q36682871-11BEE825-FB21-41BC-B3F2-A15BC810D241Q36817286-A20C19B2-F517-4790-9C98-FF1915DC0B33Q36963631-580F86B8-0201-4200-BBBF-214814787094Q37064709-E4DD06DF-57E4-4D5A-85D7-84CB8E3C6133Q37182921-AF63FE5B-F8F3-4A5A-AC4B-4F06D2AA940FQ37302745-8037E9B4-26F2-473C-908E-3B7696455902Q37798272-841410E7-B80D-45FE-AAC1-FC52924D28EFQ38116267-5CEAF52C-D6B0-4EC9-93E6-E8DCC583DB93Q38126394-CDF64420-33FD-406C-A2C8-C3401865E6D6Q38561421-B1C97299-09D4-471B-8082-6E3CB09FF910Q39697634-4B149968-D148-46D2-AB56-F73E46A3609BQ39709805-D42C8360-6BB1-4953-9004-BFA7F5B4012DQ41821353-D0549983-0E1F-4E08-93B8-B17214427431Q42212985-A07A0152-ACFE-453B-AC1D-6C7443BB1D60Q44183135-276060F9-16FC-4C20-A6BB-BA1B6F54E54FQ50655317-09A51D56-C428-4758-AD83-0F99FBD6F832Q51049632-C446F808-6CE0-4DEB-BE4A-2366786F0EF6
P2860
Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular analysis of survivin ...... do not play a role in mitosis
@ast
Molecular analysis of survivin ...... do not play a role in mitosis
@en
Molecular analysis of survivin ...... do not play a role in mitosis
@en-gb
Molecular analysis of survivin ...... do not play a role in mitosis
@nl
type
label
Molecular analysis of survivin ...... do not play a role in mitosis
@ast
Molecular analysis of survivin ...... do not play a role in mitosis
@en
Molecular analysis of survivin ...... do not play a role in mitosis
@en-gb
Molecular analysis of survivin ...... do not play a role in mitosis
@nl
prefLabel
Molecular analysis of survivin ...... do not play a role in mitosis
@ast
Molecular analysis of survivin ...... do not play a role in mitosis
@en
Molecular analysis of survivin ...... do not play a role in mitosis
@en-gb
Molecular analysis of survivin ...... do not play a role in mitosis
@nl
P2093
P2860
P356
P1476
Molecular analysis of survivin ...... do not play a role in mitosis
@en
P2093
Ana Carvalho
Carlene Starck
Elizabeth A Noton
Paul Ko Ferrigno
Rita Colnaghi
Sally P Wheatley
Sharon Tate
P2860
P304
P356
10.1074/JBC.M508773200
P407
P577
2006-01-13T00:00:00Z